Reporting guidelines for artificial intelligence in healthcare research
Open Access
- 6 May 2021
- journal article
- review article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 49 (5) , 470-476
Abstract
Reporting guidelines are structured tools developed using explicit methodology that specify the minimum information required by researchers when reporting a study. The use of artificial intelligence (AI) reporting guidelines that address potential sources of bias specific to studies involving AI interventions has the potential to improve the quality of AI studies, through improvements in their design and delivery, and the completeness and transparency of their reporting. With a number of guidance documents relating to AI studies emerging from different specialist societies, this Review article provides researchers with some key principles for selecting the most appropriate reporting guidelines for a study involving an AI intervention. As the main determinants of a high‐quality study are contained within the methodology of the study design rather than the intervention, researchers are recommended to use reporting guidelines that are specific to the study design, and then supplement them with AI‐specific guidance contained within available AI reporting guidelines.Keywords
This publication has 36 references indexed in Scilit:
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial ProtocolsJAMA, 2018
- Dermatologist-level classification of skin cancer with deep neural networksNature, 2017
- Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep LearningInvestigative Ophthalmology & Visual Science, 2016
- STARD 2015: an updated list of essential items for reporting diagnostic accuracy studiesBMJ, 2015
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statementBMJ, 2014
- Reporting of Patient-Reported Outcomes in Randomized TrialsJAMA, 2013
- Prognosis Research Strategy (PROGRESS) 3: Prognostic Model ResearchPLOS Medicine, 2013
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsBMJ, 2013
- Consort 2010 statement: extension to cluster randomised trialsBMJ, 2012
- Understanding controlled trials: Why are randomised controlled trials important?BMJ, 1998